Wiley-Blackwell logo

Publisher: Wiley-Blackwell

Related content
Volume 3, Number 2, April/May/June 2001

< previous issue | all issues

HER-Kinase-Directed Therapy of Prostate Cancer
pp. 53-58(6)
Authors: Solit D.B.; Agus D.B.

A Phase II Trial of Humanized Anti-Vascular Endothelial Growth Factor Antibody for the Treatment of Androgen-Independent Prostate Cancer
pp. 65-70(6)
Authors: Reese D.M.; Fratesi P.; Corry M.; Novotny W.; Holmgren E.; Small E.J.

Treatment of Metastatic Hormone Refractory Prostate Cancer with Ketoconazole, Hydrocortisone, and Cyclophosphamide
pp. 71-75(5)
Authors: Pecora A.; Richter F.; Pavlick A.; Lanteri V.; Scheuch J.; Levy S.; Rosenberg G.; Vitenson J.

Expression of Prostate Specific Molecules in Bacille Calmette-Guerin: An Immunotherapeutic Approach to Prostate Cancer
pp. 92-97(6)
Authors: Zeoli C.D.; Maitland M.; Rose H.; Bloom B.; Mittelman A.; Geliebter J.

Intermediate-Term Outcome with Radical Prostatectomy for Localized Prostate Cancer: The Cleveland Clinic Experience
pp. 118-125(8)
Authors: Clark P.E.; Levin H.S.; Kupelian P.A.; Reddy C.; Zippe C.D.; Klein E.A.

< previous issue | all issues

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page